| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 20.73M | — |
| Operating expense | — | — |
| Net income | -5.90M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, TBPH returned +22.3% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -9.1% |
| 1 year | +22.3% |
| 5 years | +104.9% |
| 10 years | -40.0% |
| All-time high | $40.33 (Apr 2017) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in TBPH would be worth today ›No. Theravance Biopharma, Inc. has not paid a dividend in the past 12 months.
Theravance Biopharma, Inc. stock trades on NASDAQ under the ticker symbol TBPH.
Theravance Biopharma, Inc. is part of the Healthcare sector.
Theravance Biopharma, Inc. has a market cap of 883.14M USD, based on the latest quote.
Theravance Biopharma, Inc. is expected to report earnings around Nov 10, 2026. That date is an estimate and has not been confirmed by the company.
